Coronavirus Vaccine: Bangavax and two other vaccines to meet human trial conditions
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
July 01, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JULY 01, 2025
Bangavax and two other vaccines to meet human trial conditions

Covid-19 in Bangladesh

TBS Report
16 June, 2021, 02:15 pm
Last modified: 16 June, 2021, 08:46 pm

Related News

  • Bangavax gets DGDA nod for human trials
  • Globe Biotech publishes Bangavax results of tests on monkeys
  • Indian Covaxin to be permitted for trial in Bangladesh
  • TBS Today: Bangavax trials face scientific and ethical concerns
  • NZ regulator approves Pfizer vaccine for 12-15 year olds

Bangavax and two other vaccines to meet human trial conditions

Globe Biotech and two Indian and Chinese drugmakers must submit documents on the effectiveness and side effects of the vaccines on monkeys

TBS Report
16 June, 2021, 02:15 pm
Last modified: 16 June, 2021, 08:46 pm
Logo of Globe Biotech Limited. Picture: Collected
Logo of Globe Biotech Limited. Picture: Collected

The Bangladesh Medical Research Council (BMRC) has set conditions for the human trial of three more coronavirus vaccines, including local drugmaker Globe Biotech's Bangavax, and two others from China and India respectively.

Before "human trials", the institutes will have to fulfil all conditions as per BMRC rules.

The decision was made at a meeting of the National Research Ethics Committee of the BMRC on Wednesday morning.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"We have decided in principle to approve the three vaccines. But they must meet certain conditions," BMRC Director, Professor Dr Ruhul Amin, told journalists after the meeting.

"All documents on the effectiveness and side effects of these vaccines on monkeys or chimpanzees must be submitted to the BMRC prior to Phase-1 trials. The issue of safety in human use will be seriously considered. If these rules are followed, we will definitely approve."

In addition to Bangavax, it has been decided in principle to approve the applications of Bharat Biotech and the Vero cell vaccine by the Institute of Medical Biology, Chinese Academy of Medical Sciences.

Two icddr,b scientists sought approval for the Chinese and Indian vaccines, and Globe Biotech for Bangavax.

Dr Ruhul Amin said, "It is not that the Globe vaccine has received approval for a clinical trial. But we are positive, even though several issues have been raised, including safety issues."

He said the three companies that have applied for first and second phase clinical trials will be informed of the Bangladesh Medical Research Council's (BMRC) decision.

"If necessary, the Contract Research Organisations (CROs) of the three companies can be called at any time to know the current status of the institutes," he added.

On 28 December, Globe Biotech, a Bangladeshi biotech firm, got approval from the Directorate General of Drug Administration (DGDA) to produce Covid-19 vaccine candidate Bangavax to carry out clinical trials.

On 16 January it submitted its trial protocol to the BMRC for the clinical trials of its Covid-19 vaccine, Bangavax.

Earlier, the company on 5 October 2020, noted that vaccine trials on rabbits and mice had shown "very promising results."

Bangladesh has so far approved the emergency use of six vaccines – Oxford-AstraZeneca, Sinopharm of China, Sputnik-V of Russia, Pfizer-BioNTech, CronaVac of China, and Johnson & Johnson.

Bangladesh / Top News

BMRC / conditonally / approves / human trial / Bangavax

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • File photo of Chattogram Port/TBS
    Ctg Port handles record 32.96 lakh containers in FY25, revenue hits Tk75,432 crore
  • Interest rates reduced for all types of savings instruments
    Interest rates reduced for all types of savings instruments
  • Thailand's Prime Minister Paetongtarn Shinawatra speaks during a press conference at the Government House, in Bangkok, Thailand, April 3, 2025. Photo: REUTERS/Athit Perawongmetha/File Photo
    Thai court suspends PM Paetongtarn Shinawatra over leaked phone call

MOST VIEWED

  • Representational image. Photo: UNB
    After 58 yrs, Ctg getting two new govt schools
  • Showkat Ali Chowdhury, the chairman of Eastern Bank Limited (EBL). File photo
    Bank accounts of Eastern Bank chairman, his family frozen
  • A Chevron gas station sign is seen in Del Mar, California, April 25, 2013. Chevron will report earnings on April 26. REUTERS/Mike Blake
    Chevron to resume Jalalabad gas project after Petrobangla clears $237m dues
  • Representational image. Photo Mumit M/TBS
    Tariff renegotiation in power sector a disaster for investors: Chinese Enterprises Association
  • Bangladesh Bank. File Photo: Collected
    Banks to remain open for transactions till 6pm today
  • NBR Office in Dhaka. File Photo: Collected
    NBR officers should captain revenue authority, businesses tell finance adviser

Related News

  • Bangavax gets DGDA nod for human trials
  • Globe Biotech publishes Bangavax results of tests on monkeys
  • Indian Covaxin to be permitted for trial in Bangladesh
  • TBS Today: Bangavax trials face scientific and ethical concerns
  • NZ regulator approves Pfizer vaccine for 12-15 year olds

Features

Illustration: TBS

Ulan Daspara: Remnants of a fishing village in Dhaka

18h | Panorama
Photo: Collected

Innovative storage accessories you’ll love

2d | Brands
Two competitors in this segment — one a flashy newcomer, the other a hybrid veteran — are going head-to-head: the GAC GS3 Emzoom and the Toyota CH-R. PHOTOS: Nafirul Haq (GAC Emzoom) and Akif Hamid (Toyota CH-R)

GAC Emzoom vs Toyota CH-R: The battle of tech vs trust

2d | Wheels
Women farmers, deeply reliant on access to natural resources for both farming and domestic survival, are among the most affected, caught between ecological collapse and inadequate structural support. Photo: Shaharin Amin Shupty

Hope in the hills: How women farmers in Bandarban are weathering the climate crisis

1d | Panorama

More Videos from TBS

July-August mass uprising: Nahid urges establishment of new settlement

July-August mass uprising: Nahid urges establishment of new settlement

35m | TBS Today
Trump signs executive order lifting sanctions on Syria

Trump signs executive order lifting sanctions on Syria

1h | TBS World
Chief Advisor inaugurates month-long program for July Movement

Chief Advisor inaugurates month-long program for July Movement

2h | TBS Today
12 million Americans to lose health insurance under US budget

12 million Americans to lose health insurance under US budget

3h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net